Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Aspen Pharma
Aspen Pharma
Activities:
Distribution
Finance
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Finance
Aspen to expand production facility in South Africa
Durban-based pharma company said it will invest US$320m at its Port Elizabeth site
Media
Lactalis eyes Aspen's infant formula division
The French dairy product manufacturer would boost its potential in the Chinese market if deal is successful
Manufacturing
Aspen Australia recommends SADE SP140 weight sorters
Decision to choose a weight sorter was based on reading online reviews
Finance
Strides to buy drug assets in Australia and Mauritius from Aspen for approximately US$300m
Part of aim to focus on areas where most value can be added, says Strides
Finance
Endo buys portfolio of branded and generic products
Acquisition supports continued growth in South Africa and adds some 60 on-market products and nearly 70 R&D pipeline programmes
Finance
GSK completes partial sale of Aspen Pharmacare Holdings shares
Proceeds from the transaction will be used for general corporate purposes
Finance
GlaxoSmithKline sells thrombosis brands to Aspen for £700m
The transaction includes a manufacturing plant in France
Subscribe now